TC Biopharm (Holdings) Plc (TCBP)

NASDAQ: TCBP · IEX Real-Time Price · USD
1.474
+0.044 (3.08%)
Mar 28, 2024, 9:31 AM EDT - Market open

Total Valuation

TCBP has a market cap or net worth of $3.47 million. The enterprise value is $4.14 million.

Market Cap 3.47M
Enterprise Value 4.14M

Important Dates

The next estimated earnings date is Monday, April 29, 2024, after market close.

Earnings Date Apr 29, 2024
Ex-Dividend Date n/a

Share Statistics

TCBP has 34,301 shares outstanding. The number of shares has increased by 307.86% in one year.

Shares Outstanding 34,301
Shares Change (YoY) +307.86%
Shares Change (QoQ) +185.61%
Owned by Insiders (%) 0.08%
Owned by Institutions (%) 5.59%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.96
Forward PS 3.44
PB Ratio 1.37
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.15
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.09, with a Debt / Equity ratio of 1.22.

Current Ratio 1.09
Quick Ratio 0.55
Debt / Equity 1.22
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -1.83

Financial Efficiency

Return on equity (ROE) is -102.40% and return on invested capital (ROIC) is -263.40%.

Return on Equity (ROE) -102.40%
Return on Assets (ROA) -14.20%
Return on Capital (ROIC) -263.40%
Revenue Per Employee $60,236
Profits Per Employee -$32,675
Employee Count 60
Asset Turnover 0.26
Inventory Turnover n/a

Taxes

Income Tax -2.14M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -95.23% in the last 52 weeks. The beta is 0.26, so TCBP's price volatility has been lower than the market average.

Beta (1Y) 0.26
52-Week Price Change -95.23%
50-Day Moving Average 1.39
200-Day Moving Average 6.72
Relative Strength Index (RSI) 49.77
Average Volume (30 Days) 3,343,077

Short Selling Information

Short Interest 638,718
Short Previous Month 196,991
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.08

Income Statement

In the last 12 months, TCBP had revenue of $3.61 million and -$1.96 million in losses. Loss per share was -$67.50.

Revenue 3.61M
Gross Profit 3.60M
Operating Income -14.79M
Pretax Income -4.09M
Net Income -1.96M
EBITDA -1.50M
EBIT -2.65M
Loss Per Share -$67.50
Full Income Statement

Balance Sheet

The company has $2.42 million in cash and $3.09 million in debt, giving a net cash position of -$669,807 or -$19.53 per share.

Cash & Cash Equivalents 2.42M
Total Debt 3.09M
Net Cash -669,807
Net Cash Per Share -$19.53
Equity / Book Value 2.53M
Book Value Per Share 73.69
Working Capital 491,211
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.81 million and capital expenditures -$423,268, giving a free cash flow of -$17.23 million.

Operating Cash Flow -16.81M
Capital Expenditures -423,268
Free Cash Flow -17.23M
FCF Per Share -$152.52
Full Cash Flow Statement

Margins

Gross margin is 99.48%, with operating and profit margins of -409.10% and -54.24%.

Gross Margin 99.48%
Operating Margin -409.10%
Pretax Margin -113.20%
Profit Margin -54.24%
EBITDA Margin -41.52%
EBIT Margin -73.23%
FCF Margin -476.85%

Dividends & Yields

TCBP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -307.86%
Shareholder Yield -307.86%
Earnings Yield -56.50%
FCF Yield -496.68%

Analyst Forecast

The average price target for TCBP is $1,400.00, which is 94,879.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target $1,400.00
Price Target Difference 94,879.65%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 15, 2023. It was a reverse split with a ratio of 1:20.

Last Split Date Dec 15, 2023
Split Type Reverse
Split Ratio 1:20

Scores

TCBP has an Altman Z-Score of -5.83 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -5.83
Piotroski F-Score 2